VivaBioCell. Delivering next-generation manufacturing solutions for sustainable cell therapies

Benefits

cGMP-compliance, Scale Out and Cost Efficiency. Enabling the transition from your manual protocol to an automated process. Learn more ⟩

Technology

Empowering your ATMP manufacturing with Automation, Flexibility, Integrated Imaging and Remote Monitoring. Learn more ⟩

NANT XL System

The evolution of automated cell expansion systems for mid- up to large-scale batch sizes. Maximum flexibility in cell expansion for clinical and commercial Advanced Therapies manufacturing needs. Learn more ⟩

NANT XL System

NANT 001 System

Seamless transition from R&D to clinical and commercial manufacturing. Automated cell expansion for small- to mid-scale batches, ideal for autologous and redistributed scale-out manufacturing. Learn more ⟩

NANT 001 System

NANT Maestro

Your cell factory dashboard. A range of Apps to help you monitor and manage all your NANT Systems from one easy, centralized and convenient interface. Learn more ⟩

NANT Maestro

Latest News

ImmunityBio + NANT 001 Bioreactor

VivaBioCell is Gold Sponsor of Advanced Therapies Virtual Congress & Expo (London, 5-6 October 2021)
We're thrilled to confirm our participation at the next Advanced Therapies Congress & Expo (London, 5-6 October 2021) as GOLD sponsor of this international event. Read more ⟩

Webinar 2021

Join us for our new webinar on September 9th 2021 (3.00 pm - CET)
We are delighted to announce the free webinar "Overcoming the challenges of ATMP manufacturing with novel automated systems for cell expansion: Tackling GMP-compliance, scalability and cost efficiency" where we will discuss the challenges of cell therapy manufacturing and how VivaBioCell automated technology helps overcome them. Read more ⟩

VivaBioCell at the "European Orthopaedic Research Society" Conference
VivaBioCell will attend next EORS Annual Meeting in Rome (15-17 September 2021) and showcase novel innovative technologies revolutionizing the approach to traditional orthopedics. Read more ⟩